2018-2023 Global Cholangitis Market Report (Status and Outlook)

October 2018 | 119 pages | ID: 209D9D72B67EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Cholangitis market for 2018-2023.

Cholangitis is an infection of the biliary tract with the potential to cause significant morbidity and mortality.
The key factors contributing to the growth of the cholangitis market are the changing lifestyle, increasing awareness of healthcare and geriatric population increase.
Over the next five years, LPI(LP Information) projects that Cholangitis will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Cholangitis market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Acute Cholangitis
• Primary Sclerosing Cholangitis
• Recurrent Pyogenic Cholangitis

Segmentation by application:

• Clinical Practise
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Taiho Pharmaceutical
• Mayo Clinic
• Bayer
• Gilead Sciences
• RiemserArzneimittel
• Zambon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Cholangitis market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Cholangitis market by identifying its various subsegments.
• Focuses on the key global Cholangitis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Cholangitis with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Cholangitis submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cholangitis Market Size 2013-2023
  2.1.2 Cholangitis Market Size CAGR by Region
2.2 Cholangitis Segment by Type
  2.2.1 Acute Cholangitis
  2.2.2 Primary Sclerosing Cholangitis
  2.2.3 Secondary Sclerosing Cholangitis
  2.2.4 Recurrent Pyogenic Cholangitis
2.3 Cholangitis Market Size by Type
  2.3.1 Global Cholangitis Market Size Market Share by Type (2013-2018)
  2.3.2 Global Cholangitis Market Size Growth Rate by Type (2013-2018)
2.4 Cholangitis Segment by Application
  2.4.1 Clinical Practise
  2.4.2 Others
2.5 Cholangitis Market Size by Application
  2.5.1 Global Cholangitis Market Size Market Share by Application (2013-2018)
  2.5.2 Global Cholangitis Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CHOLANGITIS BY PLAYERS

3.1 Global Cholangitis Market Size Market Share by Players
  3.1.1 Global Cholangitis Market Size by Players (2016-2018)
  3.1.2 Global Cholangitis Market Size Market Share by Players (2016-2018)
3.2 Global Cholangitis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CHOLANGITIS BY REGIONS

4.1 Cholangitis Market Size by Regions
4.2 Americas Cholangitis Market Size Growth
4.3 APAC Cholangitis Market Size Growth
4.4 Europe Cholangitis Market Size Growth
4.5 Middle East & Africa Cholangitis Market Size Growth

5 AMERICAS

5.1 Americas Cholangitis Market Size by Countries
5.2 Americas Cholangitis Market Size by Type
5.3 Americas Cholangitis Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cholangitis Market Size by Countries
6.2 APAC Cholangitis Market Size by Type
6.3 APAC Cholangitis Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Cholangitis by Countries
7.2 Europe Cholangitis Market Size by Type
7.3 Europe Cholangitis Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cholangitis by Countries
8.2 Middle East & Africa Cholangitis Market Size by Type
8.3 Middle East & Africa Cholangitis Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CHOLANGITIS MARKET FORECAST

10.1 Global Cholangitis Market Size Forecast (2018-2023)
10.2 Global Cholangitis Forecast by Regions
  10.2.1 Global Cholangitis Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Cholangitis Forecast by Type
10.8 Global Cholangitis Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Taiho Pharmaceutical
  11.1.1 Company Details
  11.1.2 Cholangitis Product Offered
  11.1.3 Taiho Pharmaceutical Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Taiho Pharmaceutical News
11.2 Mayo Clinic
  11.2.1 Company Details
  11.2.2 Cholangitis Product Offered
  11.2.3 Mayo Clinic Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Mayo Clinic News
11.3 Bayer
  11.3.1 Company Details
  11.3.2 Cholangitis Product Offered
  11.3.3 Bayer Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Bayer News
11.4 Gilead Sciences
  11.4.1 Company Details
  11.4.2 Cholangitis Product Offered
  11.4.3 Gilead Sciences Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Gilead Sciences News
11.5 RiemserArzneimittel
  11.5.1 Company Details
  11.5.2 Cholangitis Product Offered
  11.5.3 RiemserArzneimittel Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 RiemserArzneimittel News
11.6 Zambon
  11.6.1 Company Details
  11.6.2 Cholangitis Product Offered
  11.6.3 Zambon Cholangitis Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Zambon News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Cholangitis
Figure Cholangitis Report Years Considered
Figure Market Research Methodology
Figure Global Cholangitis Market Size Growth Rate 2013-2023 ($ Millions)
Table Cholangitis Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Acute Cholangitis
Table Major Players of Primary Sclerosing Cholangitis
Table Major Players of Secondary Sclerosing Cholangitis
Table Major Players of Recurrent Pyogenic Cholangitis
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Cholangitis Market Size Market Share by Type (2013-2018)
Figure Global Cholangitis Market Size Market Share by Type (2013-2018)
Figure Global Acute Cholangitis Market Size Growth Rate
Figure Global Primary Sclerosing Cholangitis Market Size Growth Rate
Figure Global Secondary Sclerosing Cholangitis Market Size Growth Rate
Figure Global Recurrent Pyogenic Cholangitis Market Size Growth Rate
Figure Cholangitis Consumed in Clinical Practise
Figure Global Cholangitis Market: Clinical Practise (2013-2018) ($ Millions)
Figure Global Clinical Practise YoY Growth ($ Millions)
Figure Cholangitis Consumed in Others
Figure Global Cholangitis Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Cholangitis Market Size by Application (2013-2018) ($ Millions)
Table Global Cholangitis Market Size Market Share by Application (2013-2018)
Figure Global Cholangitis Market Size Market Share by Application (2013-2018)
Figure Global Cholangitis Market Size in Clinical Practise Growth Rate
Figure Global Cholangitis Market Size in Others Growth Rate
Table Global Cholangitis Revenue by Players (2016-2018) ($ Millions)
Table Global Cholangitis Revenue Market Share by Players (2016-2018)
Figure Global Cholangitis Revenue Market Share by Players in 2017
Table Global Cholangitis Key Players Head office and Products Offered
Table Cholangitis Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Cholangitis Market Size by Regions 2013-2018 ($ Millions)
Table Global Cholangitis Market Size Market Share by Regions 2013-2018
Figure Global Cholangitis Market Size Market Share by Regions 2013-2018
Figure Americas Cholangitis Market Size 2013-2018 ($ Millions)
Figure APAC Cholangitis Market Size 2013-2018 ($ Millions)
Figure Europe Cholangitis Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Cholangitis Market Size 2013-2018 ($ Millions)
Table Americas Cholangitis Market Size by Countries (2013-2018) ($ Millions)
Table Americas Cholangitis Market Size Market Share by Countries (2013-2018)
Figure Americas Cholangitis Market Size Market Share by Countries in 2017
Table Americas Cholangitis Market Size by Type (2013-2018) ($ Millions)
Table Americas Cholangitis Market Size Market Share by Type (2013-2018)
Figure Americas Cholangitis Market Size Market Share by Type in 2017
Table Americas Cholangitis Market Size by Application (2013-2018) ($ Millions)
Table Americas Cholangitis Market Size Market Share by Application (2013-2018)
Figure Americas Cholangitis Market Size Market Share by Application in 2017
Figure United States Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Canada Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Cholangitis Market Size Growth 2013-2018 ($ Millions)
Table APAC Cholangitis Market Size by Countries (2013-2018) ($ Millions)
Table APAC Cholangitis Market Size Market Share by Countries (2013-2018)
Figure APAC Cholangitis Market Size Market Share by Countries in 2017
Table APAC Cholangitis Market Size by Type (2013-2018) ($ Millions)
Table APAC Cholangitis Market Size Market Share by Type (2013-2018)
Figure APAC Cholangitis Market Size Market Share by Type in 2017
Table APAC Cholangitis Market Size by Application (2013-2018) ($ Millions)
Table APAC Cholangitis Market Size Market Share by Application (2013-2018)
Figure APAC Cholangitis Market Size Market Share by Application in 2017
Figure China Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Japan Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Korea Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure India Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Australia Cholangitis Market Size Growth 2013-2018 ($ Millions)
Table Europe Cholangitis Market Size by Countries (2013-2018) ($ Millions)
Table Europe Cholangitis Market Size Market Share by Countries (2013-2018)
Figure Europe Cholangitis Market Size Market Share by Countries in 2017
Table Europe Cholangitis Market Size by Type (2013-2018) ($ Millions)
Table Europe Cholangitis Market Size Market Share by Type (2013-2018)
Figure Europe Cholangitis Market Size Market Share by Type in 2017
Table Europe Cholangitis Market Size by Application (2013-2018) ($ Millions)
Table Europe Cholangitis Market Size Market Share by Application (2013-2018)
Figure Europe Cholangitis Market Size Market Share by Application in 2017
Figure Germany Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure France Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure UK Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Italy Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Russia Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Spain Cholangitis Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Cholangitis Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Cholangitis Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Cholangitis Market Size Market Share by Countries in 2017
Table Middle East & Africa Cholangitis Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Cholangitis Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Cholangitis Market Size Market Share by Type in 2017
Table Middle East & Africa Cholangitis Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Cholangitis Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Cholangitis Market Size Market Share by Application in 2017
Figure Egypt Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Israel Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Cholangitis Market Size Growth 2013-2018 ($ Millions)
Figure Global Cholangitis arket Size Forecast (2018-2023) ($ Millions)
Table Global Cholangitis Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Cholangitis Market Size Market Share Forecast by Regions
Figure Americas Cholangitis Market Size 2018-2023 ($ Millions)
Figure APAC Cholangitis Market Size 2018-2023 ($ Millions)
Figure Europe Cholangitis Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Cholangitis Market Size 2018-2023 ($ Millions)
Figure United States Cholangitis Market Size 2018-2023 ($ Millions)
Figure Canada Cholangitis Market Size 2018-2023 ($ Millions)
Figure Mexico Cholangitis Market Size 2018-2023 ($ Millions)
Figure Brazil Cholangitis Market Size 2018-2023 ($ Millions)
Figure China Cholangitis Market Size 2018-2023 ($ Millions)
Figure Japan Cholangitis Market Size 2018-2023 ($ Millions)
Figure Korea Cholangitis Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Cholangitis Market Size 2018-2023 ($ Millions)
Figure India Cholangitis Market Size 2018-2023 ($ Millions)
Figure Australia Cholangitis Market Size 2018-2023 ($ Millions)
Figure Germany Cholangitis Market Size 2018-2023 ($ Millions)
Figure France Cholangitis Market Size 2018-2023 ($ Millions)
Figure UK Cholangitis Market Size 2018-2023 ($ Millions)
Figure Italy Cholangitis Market Size 2018-2023 ($ Millions)
Figure Russia Cholangitis Market Size 2018-2023 ($ Millions)
Figure Spain Cholangitis Market Size 2018-2023 ($ Millions)
Figure Egypt Cholangitis Market Size 2018-2023 ($ Millions)
Figure South Africa Cholangitis Market Size 2018-2023 ($ Millions)
Figure Israel Cholangitis Market Size 2018-2023 ($ Millions)
Figure Turkey Cholangitis Market Size 2018-2023 ($ Millions)
Figure GCC Countries Cholangitis Market Size 2018-2023 ($ Millions)
Table Global Cholangitis Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Cholangitis Market Size Market Share Forecast by Type (2018-2023)
Table Global Cholangitis Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Cholangitis Market Size Market Share Forecast by Application (2018-2023)
Table Taiho Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Taiho Pharmaceutical Cholangitis Revenue and Gross Margin (2016-2018)
Figure Taiho Pharmaceutical Cholangitis Market Share (2016-2018)
Table Mayo Clinic Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mayo Clinic Cholangitis Revenue and Gross Margin (2016-2018)
Figure Mayo Clinic Cholangitis Market Share (2016-2018)
Table Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer Cholangitis Revenue and Gross Margin (2016-2018)
Figure Bayer Cholangitis Market Share (2016-2018)
Table Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Gilead Sciences Cholangitis Revenue and Gross Margin (2016-2018)
Figure Gilead Sciences Cholangitis Market Share (2016-2018)
Table RiemserArzneimittel Basic Information, Head Office, Major Market Areas and Its Competitors
Table RiemserArzneimittel Cholangitis Revenue and Gross Margin (2016-2018)
Figure RiemserArzneimittel Cholangitis Market Share (2016-2018)
Table Zambon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Zambon Cholangitis Revenue and Gross Margin (2016-2018)
Figure Zambon Cholangitis Market Share (2016-2018)